公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2014 | EORTC QLQ-BM22 quality of life evaluation and pain outcome in patients with bone metastases from breast cancer treated with zoledronic acid | Yeh D.-C.; Chen D.-R.; Chao T.-Y.; Chen S.-C.; Wang H.-C.; Rau K.-M.; Feng Y.-H.; Chang Y.-C.; Lee K.-D.; Ou-Yang F.; WEN-HUNG KUO ; KING-JEN CHANG ; Lin Y.-C.; Tseng L.-M.; Hou M.-F. | In Vivo | 6 | 7 | |
2013 | Factors influencing health related quality of life in cancer patients with bone metastases | Wong E.; Chow E.; Zhang L.; Bedard G.; Lam K.; Fairchild A.; Vassiliou V.; Alm El-Din M.A.; Jesus-Garcia R.; Kumar A.; Forges F.; Tseng L.-M.; Hou M.-F.; WEI-CHU CHIE ; Bottomley A. | Journal of Palliative Medicine | 17 | 15 | |
2014 | Filtering performance of reducing the sampling rate of sound card: Perspectives on different signal-to-noise ratios | Lu B.-Y.; Tseng L.-M.; Hsu L.-Y.; Weng Y.-L.; Tang S.-H.; Hsueh M.-N.; HUEY-DONG WU ; Lai J.-S. | International Conference on Advanced Communication Technology, ICACT | 0 | 0 | |
2020 | Globo H-KLH vaccine adagloxad simolenin (OBI-822)/OBI-821 in patients with metastatic breast cancer: phase II randomized, placebo-controlled study | CHIUN-SHENG HUANG ; Yu A.L.; Tseng L.-M.; Chow L.W.C.; Hou M.-F.; Hurvitz S.A.; Schwab R.B.; L Murray J.; Chang H.-K.; Chang H.-T.; Chen S.-C.; Kim S.-B.; Hung J.-T.; Ueng S.-H.; Lee S.-H.; Chen C.-C.; Rugo H.S. | Journal for immunotherapy of cancer | 30 | 27 | |
2012 | International field testing of the reliability and validity of the EORTC QLQ-BM22 module to assess health-related quality of life in patients with bone metastases | Chow E.; Nguyen J.; Zhang L.; Tseng L.-M.; Hou M.-F.; Fairchild A.; Vassiliou V.; Jesus-Garcia R.; Alm El-Din M.A.; Kumar A.; Forges F.; WEI-CHU CHIE ; Bottomley A. | Cancer | 66 | 55 | |
2012 | An international prospective study establishing minimal clinically important differences in the EORTC QLQ-BM22 and QLQ-C30 in cancer patients with bone metastases | Zeng L.; Chow E.; Zhang L.; Tseng L.-M.; Hou M.-F.; Fairchild A.; Vassiliou V.; Jesus-Garcia R.; El-Din M.A.A.; Kumar A.; Forges F.; WEI-CHU CHIE ; Bedard G.; Bottomley A. | Supportive Care in Cancer | 28 | 19 | |
2005 | Laparoscopic appendectomy in pregnancy | Wu J.-M.; Chen K.-H.; Lin H.-F.; Tseng L.-M.; SHENG-HONG TSENG ; Huang S.-H. | Journal of Laparoendoscopic and Advanced Surgical Techniques - Part A | 43 | 30 | |
2006 | Laparoscopic Versus Open Appendectomy for Perforated Appendicitis | Lin H.-F.; Wu J.-M.; Tseng L.-M.; Chen K.-H.; Huang S.-H.; I-RUE LAI | Journal of Gastrointestinal Surgery | 68 | 58 | |
2021 | Molecular subtyping of breast cancer intrinsic taxonomy with oligonucleotide microarray and NanoString nCounter | Chen Y.-J.; Huang C.-S.; Phan N.-N.; TZU-PIN LU ; Liu C.-Y.; Huang C.-J.; Chiu J.-H.; Tseng L.-M.; Huang C.-C. | Bioscience Reports | 7 | 4 | |
2021 | Pertuzumab and trastuzumab as adjuvant treatment for HER2-positive early breast cancer: outcomes in Chinese patients in the APHINITY study | Shao Z.; Tseng L.-M.; CHIUN-SHENG HUANG ; Pang D.; Yang Y.; Li W.; Liao N.; Geng C.; Zhang Q.; Xu B.; Liu D.; Kwong A.; et al (continued in the appendix) | Japanese journal of clinical oncology | 2 | 1 | |
2021 | A phase ib study of alpelisib or buparlisib combined with tamoxifen plus goserelin in premenopausal women with HR-positive HER2-negative advanced breast cancer | YEN-SHEN LU ; Lee K.S.; Chao T.-Y.; Tseng L.-M.; Chitapanarux I.; Chen S.-C.; Liu C.-T.; Sohn J.; Kim J.H.; Chang Y.-C.; Yang Y.; Shotelersuk K.; Jung K.H.; Valenti R.; Slader C.; Gao M.; Park Y.H. | Clinical Cancer Research | 23 | 16 | |
2011 | Phase II study of docetaxel, capecitabine, and cisplatin as neoadjuvant chemotherapy for locally advanced breast cancer | YEN-SHEN LU ; Chen D.-R.; Tseng L.-M.; Yeh D.-C.; Chen S.-T.; Hsieh C.-M.; Wang H.-C.; Yeh H.-T.; SUNG-HSIN KUO ; CHIUN-SHENG HUANG | Cancer Chemotherapy and Pharmacology | 10 | 8 | |
2014 | Predictive factors of overall quality of life in advanced cancer patients using EORTC QLQ-C30 | Cramarossa G.; Zeng L.; Zhang L.; Tseng L.-M.; Hou M.-F.; Fairchild A.; Vassiliou V.; Jesus-Garcia R.; Alm El-Din M.A.; Kumar A.; Forges F.; WEI-CHU CHIE ; Sahgal A.; Lam H.; Pulenzas N.; Chow E. | Expert Review of Pharmacoeconomics and Outcomes Research | 7 | 7 | |
2013 | Predictive factors of overall well-being using the EORTC QLQ-C15-PAL extracted from the EORTC QLQ-C30 | Lam K.; Zeng L.; Zhang L.; Tseng L.-M.; Hou M.-F.; Fairchild A.; Vassiliou V.; Jesus-Garcia R.; El-Din M.A.A.; Kumar A.; Pharmd F.F.; WEI-CHU CHIE ; Sahgal A.; Poon M.; Chow E. | Journal of Palliative Medicine | 11 | 10 | |
2012 | Quality of life after palliative radiation therapy for patients with painful bone metastases: Results of an international study validating the EORTC QLQ-BM22 | Zeng L.; Chow E.; Bedard G.; Zhang L.; Fairchild A.; Vassiliou V.; Alm El-Din M.A.; Jesus-Garcia R.; Kumar A.; Forges F.; Tseng L.-M.; Hou M.-F.; WEI-CHU CHIE ; Bottomley A. | International Journal of Radiation Oncology Biology Physics | 80 | 68 | |
2013 | Quality of life assessment in Taiwanese patients with bone metastases from breast cancer receiving zoledronic acid | Chao T.-C.; Chen D.-R.; Chao T.-Y.; Chen S.-C.; Yeh D.-C.; Wang H.-C.; Huang W.-T.; Rau K.-M.; KING-JEN CHANG ; Yang T.-L.; Lee K.-D.; Tai C.-J.; Tseng L.-M.; Hou M.-F. | Anticancer Research | 1 | ||
2013 | Reduction of the noise in the respiration sound recording by the optimal sampling rate of sound card: A preliminary study | Lu B.-Y.; JIN-SHIN LAI ; HUEY-DONG WU ; Chen Y.-R.; Weng Y.-L.; Tang S.-H.; Chen Y.-L.; Tseng L.-M. | International Conference on Advanced Communication Technology, ICACT | |||
2021 | Residual risk stratification of Taiwanese breast cancers following curative therapies with the extended concurrent genes signature | Huang C.-S.; TZU-PIN LU ; Liu C.-Y.; Huang C.-J.; Chiu J.-H.; Chen Y.-J.; Tseng L.-M.; Huang C.-C. | Breast Cancer Research and Treatment | 4 | 4 | |
2012 | ROCKII Ser 1366 phosphorylation reflects the activation status | Chuang H.-H.; Yang C.-H.; Tsay Y.-G.; Hsu C.-Y.; Tseng L.-M.; ZEE-FEN CHANG ; Lee H.-H. | Biochemical Journal | 32 | 30 | |
2016 | Symptom clusters analysis in bone metastases patients | Chiu L.; Chow E.; Chiu N.; Zhang L.; Bedard G.; Fairchild A.; Vassiliou V.; El-Din M.A.A.; Jesus-Garcia R.; Forges F.; Tseng L.-M.; Hou M.-F.; WEI-CHU CHIE ; Satoh T.; Ma B.B.; Lam H.; Bottomley A. | Cancer: Pain and Symptom Management | 0 |